- Home
- RVPH vs ORMP Comparison
RVPH vs ORMP Comparison
Compare RVPH & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- ORMP
- Stock Information
- Founded
- RVPH 2006
- ORMP 2002
- Country
- RVPH United States
- ORMP United States
- Employees
- RVPH N/A
- ORMP N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- RVPH Health Care
- ORMP Health Care
- Exchange
- RVPH Nasdaq
- ORMP Nasdaq
- Market Cap
- RVPH 32.8M
- ORMP N/A
- IPO Year
- RVPH N/A
- ORMP N/A
- Fundamental
- Price
- RVPH $0.39
- ORMP $2.09
- Analyst Decision
- RVPH Strong Buy
- ORMP Hold
- Analyst Count
- RVPH 5
- ORMP 1
- Target Price
- RVPH $9.00
- ORMP N/A
- AVG Volume (30 Days)
- RVPH 3.7M
- ORMP 64.6K
- Earning Date
- RVPH 08-13-2025
- ORMP 08-15-2025
- Dividend Yield
- RVPH N/A
- ORMP N/A
- EPS Growth
- RVPH N/A
- ORMP N/A
- EPS
- RVPH N/A
- ORMP N/A
- Revenue
- RVPH N/A
- ORMP $2,000,000.00
- Revenue This Year
- RVPH N/A
- ORMP N/A
- Revenue Next Year
- RVPH N/A
- ORMP N/A
- P/E Ratio
- RVPH N/A
- ORMP N/A
- Revenue Growth
- RVPH N/A
- ORMP 196.74
- 52 Week Low
- RVPH $0.30
- ORMP $1.82
- 52 Week High
- RVPH $4.28
- ORMP $3.09
- Technical
- Relative Strength Index (RSI)
- RVPH 35.22
- ORMP 43.61
- Support Level
- RVPH $0.38
- ORMP $2.10
- Resistance Level
- RVPH $0.45
- ORMP $2.20
- Average True Range (ATR)
- RVPH 0.05
- ORMP 0.07
- MACD
- RVPH 0.01
- ORMP -0.00
- Stochastic Oscillator
- RVPH 17.57
- ORMP 0.00
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.